Results 171 to 180 of about 59,932 (250)

Remdesivir for the Treatment of Covid-19 - Preliminary Report.

New England Journal of Medicine, 2020
Z. McCaw, D. H. Kim, Lee-Jen Wei
semanticscholar   +1 more source

Direkte Katalytische C‐Glykosylierung von Arenen: beschleunigte Synthese des Remdesivir‐Nucleosids** [PDF]

, 2021
Carla Obradors, Benjamin Mitschke, Miles H. Aukland, Markus Leutzsch, Oleg Grossmann, Sebastian Brunen, Sebastian Schwengers, Benjamin List   +7 more
openalex   +1 more source

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

The Lancet Respiratory Medicine, 2023
A. Amstutz, B. Speich, F. Mentré, C. Rueegg, D. Belhadi, L. Assoumou, C. Burdet, S. Murthy, L. Dodd, Ye-ming Wang, K. Tikkinen, F. Ader, M. Hites, M. Bouscambert, M. Trabaud, Mike Fralick, Todd C Lee, R. Pinto, A. Barratt-Due, F. Lund-Johansen, F. Müller, O. Nevalainen, Bin Cao, Tyler Bonnett, Alexandra N. Griessbach, Ala Taji Heravi, C. Schönenberger, P. Janiaud, L. Werlen, S. Aghlmandi, S. Schandelmaier, Y. Yazdanpanah, D. Costagliola, Inge Christoffer Olsen, M. Briel   +34 more
semanticscholar   +1 more source

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

, 2021
Khushboo Bafna, Kris M. White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas Acton, Elena Moreno, Thomas Kehrer, Lisa Miorin, Catherine A. Royer, Adolfo Garcı́a-Sastre, Robert M. Krug, G.T. Montelione   +12 more
openalex   +1 more source

Remdesivir as a potential antiviral agent for COVID-19: A literature review

, 2020
Susanna Josey
openalex   +1 more source

SARS CoV-2 Vaccines, Remdesivir and Favipiravir Might Have Led to SARS CoV-2 B.1.617 Variants: India First but We Can Intervene [PDF]

, 2021
Mina Kelleni
openalex   +1 more source

Prediction of in‐hospital mortality with machine learning for COVID‐19 patients treated with steroid and remdesivir [PDF]

, 2021
Toshiki Kuno, Yuki Sahashi, Shinpei Kawahito, Mai Takahashi, Masao Iwagami, Natalia Egorova   +5 more
openalex   +1 more source

Treatment of patients hospitalized for COVID-19 with remdesivir is associated with lower likelihood of 30-day readmission: a retrospective observational study

Journal of Comparative Effectiveness Research
Aim: This observational study investigated the association between remdesivir treatment during hospitalization for COVID-19 and 30-day COVID-19-related and all-cause readmission across different variants time periods.
Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Andre C Kalil, Vishnudas Sarda, Celine Der-Torossian, Thomas Oppelt, Mark Berry, Alpesh N Amin   +9 more
doaj   +1 more source

Time-varying characteristics of remdesivir-treated patients hospitalised due to COVID-19: an electronic health record study. [PDF]

J Glob Health
Hoe JK, Blond K, Jimenez-Solem E, Berry M, Chiang M, Ankarfeldt MZ, Petersen J.   +6 more
europepmc   +1 more source

Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiong X, Chen Z, Yan B.
europepmc   +1 more source